IFNL3 and cryohydrocytosis: Genetic variations near the interleukin 28B (IL28B) gene, encoding type III IFN-λ3, were shown to be strongly associated with the response to peg-IFN and ribavirin treatment in patients with CHC [17]–[20] and with spontaneous clearance of HCV [21].